Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LGND
RYTM
Add up to 3 more stocks
LGND
Ligand Pharmaceuticals Incorporated
-3.20%
$296.94-9.83Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$5.95B
52W Range
$175.89 - $326.63
RYTM
Rhythm Pharmaceuticals, Inc.
-1.82%
$90.77-1.68Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$6.23B
52W Range
$74.50 - $122.20
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 31.76 | N/A |
| Forward P/E | 31.91 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 6.15 | 60.46 |
| P/S Ratio | 20.48 | 25.95 |
| P/FCF Ratio | 45.30 | N/A |
| EV/EBITDA | 45.02 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 98.6% | 89.0% |
| Operating Margin | 17.6% | -101.2% |
| Net Margin | 67.9% | -85.6% |
| ROE | 20.4% | -94.5% |
| ROA | 9.0% | -47.0% |
| ROIC | 3.9% | -64.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 31.18 | 3.45 |
| Quick Ratio | 30.96 | 3.20 |
| Debt/Equity | 1.17 | 0.02 |
| Interest Coverage | 10.01 | -9.33 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.